Concepedia

Keith A. Earle

KA

Statistics

Publications

4

Citations

492

H-Index

4

Active since

1999

Affiliations

Pathways Behavioral Services(Current)

Keith A. Earle is an author at Pathways Behavioral Services specializing in oncology, pharmacology, and cytotoxic chemotherapy.

Publications per year

1999–2003

4

Publications

4

Rapid development of colitis in NSAID-treated IL-10–deficient mice

Daniel Berg, Juan Zhang, Joel V. Weinstock et al. · Gastroenterology · 2002 · 277 citations · Full text

Life Sciences, Immunology, Pathology +14

Exisulind-induced apoptosis in a non-small cell lung cancer orthotopic lung tumor model augments docetaxel treatment and contributes to increased survival.

Clark M. Whitehead, Keith A. Earle, John Fetter et al. · PubMed · 2003 · 102 citations

Medicine, Oncology, Pharmacology +17

Exisulind in combination with docetaxel inhibits growth and metastasis of human lung cancer and prolongs survival in athymic nude rats with orthotopic lung tumors.

Daniel C. Chan, Keith A. Earle, Tom Zhao et al. · PubMed · 2002 · 65 citations

Medicine, Oncology, Pharmacology +15

Synergistic Effect of Formulated Plasmid and Needle-Free Injection for Genetic Vaccines

Khursheed Anwer, Keith A. Earle, Mei Shi et al. · Pharmaceutical Research · 1999 · 48 citations

Pharmacy, Biotechnology, Pharmaceutical Biotechnology +16

1–4 of 4